Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Step 6 Conducting Management Review

Values-Based Scrfety Process Improving Your Safety Culture With Behavior-Based Safety, J25 [Pg.125]

Second Edition Terry E. McSween Copyright 2003 John Wiley Sons, Inc. ISBN 0-471-22049-3 [Pg.125]

Once you have completed your planning efforts, the design team should present the behavioral safety process to management for its input and review. This step should be a cricital milestone on your initial schedule. This meeting is an opportunity for management to [Pg.126]

All design team members should participate in the presentation. Each design team member should take responsibility for presenting one agenda item, with all members participating in a question-and-answer session at the end. Managers will [Pg.126]

Purpose Get management s input and approval for the design team s plans  [Pg.126]


The project review process involves multiple steps that should be definea in management gmdelines (CCPS, 1993, pp. 57-61). The steps include (1) review pohcy, (2) review scheduling, (3) reviewtech-nique, (4) review team representation, (5) review documentation, (6) review follow-up, (7) review follow-up verification, and (8) review procedures change management. These steps define how a review, whether it be a safety review, environmental review, pre-start-up review, or whatever, is conducted and how closure of review aclion items is achieved. [Pg.2285]

Conduct a review with management as described below, then proceed to step 5, conduct training and kickoff meetings in each area. [Pg.92]

For additional information and hands-on practice conducting a pharmacoeconomic evaluation in the real world, practitioners should consider a recently published case study. In 2003, Okamoto published a case smdy on conducting a pharmacoeconomic evaluation using 16 steps that readers also may Hnd useful. In this case, chn-icians are challenged to conduct a faux economic analysis from an MCO (provider) perspective to support a review of inhaled corticosteroids for formulary management purposes. [Pg.13]

Step 9. If the candidate raw material is approved and the supplier is a new suppher, the EHS Manager is responsible for notifying the Responsible Care Supplier Audit Team of the need for a new supplier audit as required in PP.20.4. (PP.20.4 should include the protocol for the conduct of a new supplier audit. The audit involves a review of the supplier s operations for operational capability, compliance with legal requirements, and Responsible Care Codes. The audit report may decline use of the supplier, accept the supplier, or accept the Supplier subject to designated corrective actions.)... [Pg.707]

This step provides for regularly scheduled reviews, at which time updates and risk evaluations are again conducted. This ensures that the risk management systems are working as expected and tests them against new information regarding hazard data and/or new or altered exposure patterns. [Pg.154]

The following sections will provide a brief summary of the 15 DMAIC steps in conducting a Six Sigma type review of the safety management system. [Pg.112]


See other pages where Step 6 Conducting Management Review is mentioned: [Pg.125]    [Pg.126]    [Pg.127]    [Pg.125]    [Pg.126]    [Pg.127]    [Pg.338]    [Pg.253]    [Pg.2003]    [Pg.48]    [Pg.600]    [Pg.57]    [Pg.27]    [Pg.2242]    [Pg.1163]    [Pg.25]    [Pg.417]    [Pg.60]    [Pg.66]   


SEARCH



Conduct Management Review

© 2024 chempedia.info